Edition:
United States

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

63.52EUR
11:35am EST
Change (% chg)

€0.34 (+0.54%)
Prev Close
€63.18
Open
€63.16
Day's High
€63.64
Day's Low
€62.82
Volume
1,117,502
Avg. Vol
1,581,910
52-wk High
€80.07
52-wk Low
€60.15

Select another date:

Sun, Jan 7 2018

Photo

Fresenius CFO backs acquisition course: Boersen-Zeitung

FRANKFURT German healthcare group Fresenius will continue to look for acquisitions even if that leads to a temporary rise in debt, Boersen-Zeitung quoted the company's finance chief as saying.

Fresenius CFO backs acquisition course -Boersen-Zeitung

FRANKFURT, Jan 7 German healthcare group Fresenius will continue to look for acquisitions even if that leads to a temporary rise in debt, Boersen-Zeitung quoted the company's finance chief as saying.

BRIEF-Fresenius says US Tax Reform ‍results In One-Time Book Gain Of about 90 mln euros

* ‍NEW US TAX LEGISLATION TRIGGERS REVALUATION OF DEFERRED TAX LIABILITIES​

Fresenius says on track to increase dividend again next year

FRANKFURT, Nov 21 German healthcare group Fresenius SE is well on its way to further increase its annual dividend next year, reflecting the prospect of earnings growth in 2017, its chief executive said.

U.S. fights Fresenius dismissal bid in Medicare billing case

The U.S. Justice Department is urging a federal judge not to dismiss some of its claims that kidney dialysis services company Fresenius SE & Co KGaA billed Medicare for medically unnecessary tests.

Fresenius wins document unsealing in U.S. false claims case

Fresenius SE & Co KGaA has secured an order to unseal portions of court documents filed by the U.S. Justice Department relating to its investigation of a whistleblower complaint accusing the kidney dialysis services company of billing for medically unnecessary services.

Senvest Management shorting drug stocks Insys, Akorn, Fresenius

TEL AVIV, Oct 3 New York-based Senvest Management is shorting three drug stocks, Insys Therapeutics Inc , Akorn Inc and Fresenius SE, its chief executive Richard Mashaal said on Tuesday,

BRIEF-Fresenius refinances 3.8 bln euro credit agreement

* Credit agreement has volume of around 3.8 billion euros, consists of revolving facilities and term loans with maturities in 2021 and 2022

Select another date: